← All trials
NCT07075510
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 23, 2025
- Primary completion
- Oct 1, 2030
- Completion date
- Oct 1, 2032
- First posted
- Jul 20, 2025
- Last posted
- Oct 29, 2025
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MarylandLead sponsor
- Johnson and JohnsonCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.